HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2011 | 1335 | 1716 | 77.8% | |
| HF 4 | 2012 | 1506 | 1841 | 81.8% | |
| HF 4 | 2013 | 1690 | 2011 | 84.0% | |
| HF004 | 2014 | 1190 | 1371 | 86.8% | |
| HF004 | 2015 | 1321 | 1469 | 89.9% | |
| HF004 | 2016 | 1532 | 1689 | 90.7% | |
| HF004 | 2017 | 1691 | 1879 | 90.0% | |
| HF004 | 2018 | 2001 | 2194 | 91.2% | |
| HF004 | 2019 | 1378 | 1543 | 89.3% | |
| HF004 | 2020 | 2564 | 2832 | 90.5% | |
| HF006 | 2021 | 3393 | 3935 | 86.2% | |
| HF006 | 2022 | 4093 | 4343 | 94.2% | |
| HF006 | 2023 | 4784 | 5159 | 92.7% |
